Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends

J Kadkhoda, A Tarighatnia, MR Tohidkia, ND Nader… - Life sciences, 2022 - Elsevier
Breast cancer (BC) has different clinical manifestations due to its diverse mechanism of
action that has created many challenges to choosing appropriate treatment. Recent findings …

CD8 T cell score as a prognostic biomarker for triple negative breast cancer

M Oshi, M Asaoka, Y Tokumaru, L Yan… - International journal of …, 2020 - mdpi.com
CD8 T cell is an essential component of tumor-infiltrating lymphocytes (TIL) and tumor
immune microenvironment (TIME). Using the xCell CD8 T cell score of whole tumor gene …

[HTML][HTML] circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression

BO Chen, W Wei, X Huang, X Xie, Y Kong, D Dai… - Theranostics, 2018 - ncbi.nlm.nih.gov
Circular RNAs (circRNAs) represent a class of non-coding RNAs that play a vital role in
modulating gene expression and several pathological responses. However, the expression …

[HTML][HTML] Trailblazing perspectives on targeting breast cancer stem cells

J Li, D Qi, TC Hsieh, JH Huang, JM Wu, E Wu - Pharmacology & …, 2021 - Elsevier
Breast cancer (BCa) is one of the most prevalent malignant tumors affecting women's health
worldwide. The recurrence and metastasis of BCa have made it a long-standing challenge …

Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative …

SM Jusu, JD Obayemi, AA Salifu, CC Nwazojie… - Scientific Reports, 2020 - nature.com
Triple-negative breast cancer (TNBC) is more aggressive and difficult to treat using
conventional bulk chemotherapy that is often associated with increased toxicity and side …

Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance

J Yang, Z Jia, J Zhang, X Pan, Y Wei… - Advanced …, 2022 - Wiley Online Library
Triple‐negative breast cancer (TNBC) patients have a predisposition to poor prognosis due
to the strong malignancy. Ferroptosis, a new form of cell death, is a candidate treatment for …

[HTML][HTML] Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer

T Fujii, T Kogawa, W Dong, AA Sahin, S Moulder… - Annals of …, 2017 - Elsevier
Background Although 1% has been used as cut-off for estrogen receptor (ER) positivity,
several studies have reported that tumors with ER< 1% have characteristics similar to those …

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

CR Tate, LV Rhodes, HC Segar, JL Driver… - Breast Cancer …, 2012 - Springer
Introduction Of the more than one million global cases of breast cancer diagnosed each
year, approximately fifteen percent are characterized as triple-negative, lacking the …

Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo

Y Zhao, Z Jing, J Lv, Z Zhang, J Lin, X Cao… - Biomedicine & …, 2017 - Elsevier
Berberine (BBR) is an isoquinoline alkaloid isolated from Cotridis rhizoma and exhibits
multiple biological roles including anti-microbe, anti-inflammation and anti-tumor activities …

CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy

AK McClendon, JL Dean, DB Rivadeneira, JE Yu… - Cell cycle, 2012 - Taylor & Francis
Triple-negative breast cancer (TNBC) is an aggressive disease that lacks established
markers to direct therapeutic intervention. Thus, these tumors are routinely treated with …